SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-22-020122
Filing Date
2022-04-15
Accepted
2022-04-15 16:06:15
Documents
2
Period of Report
2022-04-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1630
2 POWER OF ATTORNEY ea158474ex24_moonlake.htm EX-24 7184
  Complete submission text file 0001213900-22-020122.txt   10335
Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
Moukheibir Catherine (Reporting) CIK: 0001772130 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39630 | Film No.: 22830104

Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Issuer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations